NCT01367561View on ClinicalTrials.gov

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Healthy Males
Interventions
DRUG

Naloxone

DRUG

IV Methylnaltrexone (MNTX)

DRUG

Placebo

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367561 - Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function | Biotech Hunter | Biotech Hunter